Wellgistics, DataVault Plan Blockchain Drug-Tracking

Wellgistics Health (NASDAQ: WGRX) and DataVault AI (NASDAQ: DVLT) announced a non-binding letter of intent to integrate DataVault’s PharmacyChain blockchain smart-contract technology into Wellgistics’ infrastructure to digitize and tokenize prescription drug tracking from prescription to fulfillment. The proposed PharmacyChain would pair DataVault’s blockchain with Wellgistics’ HubRx AI and its network of more than 6,500 independent pharmacies, aiming to increase transparency, deter counterfeit medicines and improve patient safety in the U.S. prescription drug market, valued at roughly $634 billion. The companies have discussed a potential revenue-sharing model tied to platform usage, but the agreement remains subject to negotiation and execution of definitive contracts. The announcement triggered a sharp market reaction: Benzinga and other outlets reported WGRX shares spiking roughly 88% in after-hours trading while DVLT traded higher, and several AI- and healthcare-themed ETFs saw modest gains. Market-data notes warn that Wellgistics is a thinly traded microcap with low liquidity, a sizable year-to-date share-price decline and mixed financial indicators, adding execution and market risk for investors. There is no assurance the collaboration will be completed or generate revenue.